✦ LIBER ✦

Blocking the bradykinin response: Pharmacodynamics and safety of icatibant, a potent and selective bradykinin B2 receptor antagonist

✍ Scribed by Jens Zimmermann; Bernd Rosenkranz; Françoise Brunner-Ferber; Jochen Knolle

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Absolute Bioavailability of Subcutaneous

✍ Wagner, F.; Rosenkranz, B.; Knolle, J. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Icatibant, a Potent and Selective Bradyk

✍ Levy, R.J.; Goodman, S. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Inhibition of bradykinin-induced vasodil

✍ JR Cockcroft; PJ Chowienczyk; SE Brett; N Bender; JM Ritter 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 880 KB

LF 16.0335, a novel potent and selective

✍ Didier Pruneau; Jean-Michel Luccarini; Chantal Fouchet; Evelyne Defrêne; Rose-Ma 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 331 KB

Safety Evaluation of Icatibant, a Select

✍ Staubach, P.; Bork, K. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Icatibant, a Selective Bradykinin B2 Rec

✍ RIEDL, M 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 44 KB